$160 million ‘moonshot’ backs Boston effort to revolutionize rare disease treatment
A new $160 million collaborative center in Boston aims to accelerate the development of genetic medicines for rare and ultra-rare diseases.
Velocity timeline
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
The Broad Institute, Boston Children's Hospital, and The Jackson Laboratory have launched the Center for Therapeutic Genetics. This non-profit initiative focuses on scaling gene therapy development to address conditions that have historically seen limited medical intervention.
Coverage from The Boston Globe, The New York Times, Yahoo Finance, Precision Medicine Online, and Wellcome highlights the collaborative nature of this project. Outlets note the objective to revolutionize treatments for rare and ultra-rare disease patients, describing the funding as a major 'moonshot' effort.
The initiative aims to change the future landscape of therapeutic genetics, though coverage does not yet specify a timeline for the center's first clinical projects. Observers are tracking how this consortium will integrate its research efforts across the involved institutions.
Synthesized by Newsylist from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 2h ago.
Quick answers
What institutions are involved in the Center for Therapeutic Genetics?
The project is a collaboration between the Broad Institute, Boston Children's Hospital, and The Jackson Laboratory.
How much funding is backing the new center?
The effort is backed by $160 million in funding.
What is the primary goal of the center?
The non-profit center aims to develop and scale genetic medicines specifically for rare and ultra-rare diseases.
Coverage (5)
- Broad Institute, Boston Children's Hospital, and The Jackson Laboratory launch the Center for Therapeutic Genetics, a non-profit effort to develop genetic medicines for rare and ultra-rare diseases Yahoo Finance · 7h ago
- New England Consortium Takes Aim at Scaling Gene Therapy Development Precision Medicine Online · 7h ago
- Gene therapy: changing the future for people with rare diseases wellcome.org · 7h ago
- ‘Too Rare to Care’? A New Center for Rare Diseases Hopes to Change That The New York Times · 7h ago
- $160 million ‘moonshot’ backs Boston effort to revolutionize rare disease treatment The Boston Globe · 7h ago broke it first
People, places & organizations
Topics
Related trends
Unpacking Anthropic's 100-day sprint into biopharma: Nobel hires, M&A and major ambition
Anthropic is rapidly expanding into biopharma through strategic hires, M&A activity, and the launch of a dedicated science AI workbench.
Red Sox reactions: Caleb Durbin’s homer in the eighth pushes streak to 14 straight
The Boston Red Sox have extended their winning streak to 14 games following a late home run by Caleb Durbin.
The Red Sox have changed the conversation
The Boston Red Sox have extended their winning streak to 12 games following a decisive victory over the Tampa Bay Rays.
Red Sox reactions: Everything to know as Boston reaches .500 for first time since March 28
The Boston Red Sox have returned to a .500 winning percentage for the first time since March 28, fueled by an 11-game winning streak.
Column
4 news sources are covering this Health story right now — Newsylist is tracking how fast it spreads.
Pending home sales dip in June as high mortgage rates, prices lead to 'tepid' market
Pending home sales hit near-record lows in June as high mortgage rates and record-setting home prices stifle buyer activity across the U.S.